LivingGLP1
Study S002705

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Registration

Registration
NCT07012642
Study type
INTERVENTIONAL
Phase
EARLY_PHASE1
Masking
NONE
Status
RECRUITING
Enrollment
110
Start
2025-04-09
Primary completion
2027-04-09
Lead sponsor
Advanced Reconstructive Surgery Alliance
Conditions
Lymphedema
Interventions
DRUG:GLP-1 Receptor Agonists
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Patient reported quality of life outcome using LLIS [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.